U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.74%

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXNPEC0K0YG_M.jpg
© Reuters. U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.74%© Reuters. U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.74%

Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the , and sectors led shares higher.

At the close in NYSE, the added 0.74% to hit a new all time high, while the index climbed 0.67%, and the index added 0.81%.

The best performers of the session on the were Apple Inc (NASDAQ:), which rose 2.12% or 6.44 points to trade at 309.63 at the close. Meanwhile, Goldman Sachs Group Inc (NYSE:) added 2.04% or 4.84 points to end at 242.60 and Coca-Cola Company (NYSE:) was up 1.82% or 0.99 points to 55.34 in late trade.

The worst performers of the session were Walgreens Boots Alliance Inc (NASDAQ:), which fell 2.06% or 1.15 points to trade at 54.68 at the close. Dow Inc (NYSE:) declined 1.02% or 0.54 points to end at 52.19 and UnitedHealth Group Incorporated (NYSE:) was down 0.57% or 1.68 points to 294.22.

The top performers on the S&P 500 were L Brands Inc (NYSE:) which rose 4.46% to 18.96, Jefferies Financial Group Inc (NYSE:) which was up 3.94% to settle at 21.90 and Align Technology Inc (NASDAQ:) which gained 3.69% to close at 296.54.

The worst performers were Kohls Corp (NYSE:) which was down 6.54% to 46.15 in late trade, Gap Inc (NYSE:) which lost 3.54% to settle at 17.43 and Capri Holdings Ltd (NYSE:) which was down 3.39% to 36.72 at the close.

The top performers on the NASDAQ Composite were Applied Genetic (NASDAQ:) which rose 122.84% to 9.27, Trillium Therapeutics Inc (NASDAQ:) which was up 93.96% to settle at 2.89 and Genetic Technologies Ltd (NASDAQ:) which gained 45.09% to close at 4.730.

The worst performers were Regulus Therapeutics Inc (NASDAQ:) which was down 19.33% to 1.210 in late trade, Bed Bath & Beyond Inc (NASDAQ:) which lost 19.22% to settle at 13.45 and Ecmoho Ltd (NASDAQ:) which was down 18.95% to 6.97 at the close.

Rising stocks outnumbered declining ones on the New York Stock Exchange by 1536 to 1281 and 93 ended unchanged; on the Nasdaq Stock Exchange, 1485 rose and 1152 declined, while 83 ended unchanged.

Shares in Jefferies Financial Group Inc (NYSE:) rose to 52-week highs; gaining 3.94% or 0.83 to 21.90. Shares in Apple Inc (NASDAQ:) rose to all time highs; gaining 2.12% or 6.44 to 309.63. Shares in Goldman Sachs Group Inc (NYSE:) rose to 52-week highs; up 2.04% or 4.84 to 242.60. Shares in Applied Genetic (NASDAQ:) rose to 52-week highs; gaining 122.84% or 5.11 to 9.27. Shares in Trillium Therapeutics Inc (NASDAQ:) rose to 52-week highs; up 93.96% or 1.40 to 2.89.

The , which measures the implied volatility of S&P 500 options, was down 6.77% to 12.54.

Gold Futures for February delivery was down 0.44% or 6.85 to $1553.35 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in February fell 0.03% or 0.02 to hit $59.59 a barrel, while the March Brent oil contract rose 0.05% or 0.03 to trade at $65.39 a barrel.

EUR/USD was up 0.01% to 1.1106, while USD/JPY rose 0.02% to 109.53.

The US Dollar Index Futures was up 0.14% at 97.132.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.